Pharmaceutical Pricing and Reimbursement Policies: lessons learnt and perspectives for Brazil
نویسندگان
چکیده
The special series “Pharmaceutical Pricing and Reimbursement Policies” published throughout 2022, was organised by invitation of the Brazilian Journal Hospital Pharmacy Health Services, to characterise medicines pricing reimbursement in Brazil other countries discuss implementation, effects, gaps opportunities for improvement. included an editorial, a perspective on Pharmaceutical Policies (PPRI) network eight country case studies, namely Austria, Brazil, Greece, Canada, Italy, United Kingdom, Portugal States. In closing series, overview is presented, as well critical appraisal how aspects such innovation, access, health litigation, importance international cooperation networking are producing advances or setbacks pharmaceutical regulation, reimbursement, in-place technology assessment. This article also highlights scenario with recent developments policies approaching pricing, incorporation (reimbursement), expenditure, at same time introducing arguments that show these issues may intertwine planning budgets, straining sustainability threatening concept comprehensiveness adopted Unified System. New perspectives strengthening life-cycle approach, aiming improving access essential medicines, stimulating innovation ensuring system needed. Experiences series´ studies examples benchmarking best practices, increasing collaboration sources inspiration.
منابع مشابه
Pharmaceutical pricing and reimbursement policies: perspectives for the future
Setting the scene For many years, the global approach to pharmaceutical pricing and reimbursement policies has been informed, first and foremost, by the key differences between those systems which relied on public sector procurement and supply, and those which were based on reimbursement. The first approach was considered to be the most appropriate for developing countries. Funding for healthca...
متن کاملChallenges and opportunities for pharmaceutical pricing and reimbursement policies
Even though access to affordable medicines is a human right, it is not ensured world-wide. The Priority Medicines Report 2013 [1] identified pharmaceutical gaps that continue to remain: diseases of public health importance for which pharmaceutical treatments either do not exist or are inadequate (see also K4). Where adequate treatments were available, access might be limited due to high costs o...
متن کامل[Health technology assessment and its impact on pharmaceutical pricing and reimbursement policies].
The article conceptualizes the pharmaceutical pricing and reimbursement policies related to financial coverage in the context of health systems. It introduces the pharmaceutical market as an imperfect one, in which appropriate regulation is required. Moreover, the basis that guide the pricing and reimbursement processes are defined and described in order to generate a categorization based on wh...
متن کاملComparing pharmaceutical pricing and reimbursement policies in Croatia to the European Union Member States
AIM To perform a comparative analysis of the pharmaceutical pricing and reimbursement systems in Croatia and the 27 European Union (EU) Member States. METHODS Knowledge about the pharmaceutical systems in Croatia and the 27 EU Member States was acquired by literature review and primary research with stakeholders. RESULTS Pharmaceutical prices are controlled at all levels in Croatia, which i...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde
سال: 2022
ISSN: ['2179-5924', '2316-7750']
DOI: https://doi.org/10.30968/rbfhss.2022.134.0897